Ignite Creation Date:
2025-12-24 @ 1:12 PM
Ignite Modification Date:
2026-01-20 @ 9:06 PM
Study NCT ID:
NCT03850795
Status:
TERMINATED
Last Update Posted:
2024-08-19
First Post:
2019-02-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Sponsor:
Hinova Pharmaceuticals USA, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HC1119-CS-03
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None